MRK vs ZBH
By Alex · Tickerpine
Merck & Co., Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ZBH |
|---|---|---|
| Price | $156.45 | $100.24 |
| Market cap | $385.99B | $19.12B |
| P/E ratio | 120.3 | 24.5 |
| ROE | 6.96% | 6.41% |
| Profit margin | 4.77% | 9.48% |
| Revenue growth | 5.10% | 4.80% |
| Dividend yield | 2.26% | 0.95% |
| Beta | 0.21 | 0.46 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ZBH in plain English
- MRK is the bigger company — about 20.2× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 24.5 vs 120.3).
- MRK earns a higher return on equity (7% vs 6%).
- MRK is growing revenue faster (5% vs 5%).
- MRK has the higher dividend yield (2.26% vs 0.95%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.